{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:35:07Z","timestamp":1774355707204,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"DOI":"10.7759\/cureus.71777","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:30:22Z","timestamp":1729261822000},"source":"Crossref","is-referenced-by-count":1,"title":["Young-Onset, ROS1-Rearranged Adenocarcinoma of the Lung With Cardiac Tamponade: A Case Report"],"prefix":"10.7759","author":[{"given":"Masafumi","family":"Nojiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryudai","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumito","family":"Nagae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0050","article-title":"ROS1 fusions in cancer: a review","volume":"12","author":"Uguen A","year":"2016","unstructured":"Uguen A, De Braekeleer M. ROS1 fusions in cancer: a review. Future Oncol. 2016, 12:1911-28. 10.2217\/fon-2016-0050","journal-title":"Future Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.6.1564","article-title":"Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?","volume":"116","author":"Atar S","year":"1999","unstructured":"Atar S, Chiu J, Forrester JS, Siegel RJ. Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?. Chest. 1999, 116:1564-9. 10.1378\/chest.116.6.1564","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4010075","article-title":"Malignant cardiac tamponade from non-small cell lung cancer: case series from the era of molecular targeted therapy","volume":"4","author":"Li BT","year":"2014","unstructured":"Li BT, Pearson A, Pavlakis N, et al.. Malignant cardiac tamponade from non-small cell lung cancer: case series from the era of molecular targeted therapy. J Clin Med. 2014, 4:75-84. 10.3390\/jcm4010075","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29020057","article-title":"ROS-1 fusions in non-small-cell lung cancer: evidence to date","volume":"29","author":"Gendarme S","year":"2022","unstructured":"Gendarme S, Bylicki O, Chouaid C, Guisier F. ROS-1 fusions in non-small-cell lung cancer: evidence to date. Curr Oncol. 2022, 29:641-58. 10.3390\/curroncol29020057","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw AT","year":"2014","unstructured":"Shaw AT, Ou SH, Bang YJ, et al.. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014, 371:1963-71. 10.1056\/NEJMoa1406766","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2020.100045","article-title":"Genomic profiling in non-small-cell lung cancer in young patients. A\u00a0systematic review","volume":"6","author":"Vi\u00f1al D","year":"2021","unstructured":"Vi\u00f1al D, Mart\u00ednez D, Higuera O, de Castro J. Genomic profiling in non-small-cell lung cancer in young patients. A\u00a0systematic review. ESMO Open. 2021, 6:100045. 10.1016\/j.esmoop.2020.100045","journal-title":"ESMO Open"},{"key":"ref7","unstructured":"National Cancer Center, National Research and Development Agency. Cancer Statistics 2019. (2024). Accessed: January 4, 2024: https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880533","article-title":"DNA copy number changes in lung adenocarcinoma in younger patients","volume":"15","author":"Lindstr\u00f6m I","year":"2002","unstructured":"Lindstr\u00f6m I, Nordling S, Niss\u00e9n AM, Tammilehto L, Mattson K, Knuutila S. DNA copy number changes in lung adenocarcinoma in younger patients. Mod Pathol. 2002, 15:372-8. 10.1038\/modpathol.3880533","journal-title":"Mod Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30539","article-title":"Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma","volume":"123","author":"Tanaka K","year":"2017","unstructured":"Tanaka K, Hida T, Oya Y, et al.. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Cancer. 2017, 123:1731-40. 10.1002\/cncr.30539","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73533-y","article-title":"CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas","volume":"10","author":"Woo JH","year":"2020","unstructured":"Woo JH, Kim TJ, Kim TS, Han J. CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas. Sci Rep. 2020, 10:16251. 10.1038\/s41598-020-73533-y","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.3.744","article-title":"Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer","volume":"118","author":"Wang PC","year":"2000","unstructured":"Wang PC, Yang KY, Chao JY, Liu JM, Perng RP, Yen SH. Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest. 2000, 118:744-9. 10.1378\/chest.118.3.744","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.4.1328","article-title":"Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy","volume":"125","author":"Cullinane CA","year":"2004","unstructured":"Cullinane CA, Paz IB, Smith D, Carter N, Grannis FW Jr. Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest. 2004, 125:1328-34. 10.1378\/chest.125.4.1328","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930101)71:1<93::aid-cncr2820710115>3.0.co;2-r","article-title":"Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion","volume":"71","author":"Okamoto H","year":"1993","unstructured":"Okamoto H, Shinkai T, Yamakido M, Saijo N. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer. 1993, 71:93-8. 10.1002\/1097-0142(19930101)71:1&lt;93::aid-cncr2820710115&gt;3.0.co;2-r","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00069812","article-title":"Survival of lung adenocarcinoma patients with malignant pleural effusion","volume":"41","author":"Wu SG","year":"2013","unstructured":"Wu SG, Yu CJ, Tsai MF, et al.. Survival of lung adenocarcinoma patients with malignant pleural effusion. Eur Respir J. 2013, 41:1409-18. 10.1183\/09031936.00069812","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.05.019","article-title":"Thromboembolism in ALK+ and ROS1+ NSCLC patients: a systematic review and meta-analysis","volume":"157","author":"Zhu VW","year":"2021","unstructured":"Zhu VW, Zhao JJ, Gao Y, et al.. Thromboembolism in ALK+ and ROS1+ NSCLC patients: a systematic review and meta-analysis. Lung Cancer. 2021, 157:147-55. 10.1016\/j.lungcan.2021.05.019","journal-title":"Lung Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306727-young-onset-ros1-rearranged-adenocarcinoma-of-the-lung-with-cardiac-tamponade-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:30:26Z","timestamp":1729261826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306727-young-onset-ros1-rearranged-adenocarcinoma-of-the-lung-with-cardiac-tamponade-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.71777","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}